Medically integrated pharmacy (MIP) is moving beyond its roots in oncology and emerging as a significant growth opportunity across specialty care. By embedding pharmacy services directly within physician practices and health systems, the model brings prescribing, dispensing, financial counseling, adherence monitoring, and clinical management together at the point of care—while creating new, durable revenue streams. […]

Home and ambulatory infusion are entering a period of significant regulatory change as federal and state policies reshape where care is delivered, how providers are reimbursed, and which operating models are positioned to create value. In this perspective, we examine the legislative and regulatory developments shaping the sector, from Medicare home infusion coverage and site-neutral […]

Home infusion providers are entering a new phase of growth, but not all specialty therapy lines offer the same strategic opportunity. As legacy infusion categories mature and reimbursement pressures increase, providers and investors are looking to higher-growth specialties that can drive long-term value creation. In this perspective, we examine the financial and operational potential of […]

Home and alternate-site infusion therapy is rapidly becoming a cornerstone of home-centered healthcare delivery. As payers shift care away from hospitals, specialty drug utilization expands, and patients seek more convenient treatment settings, infusion providers are taking on an increasingly strategic role across the healthcare ecosystem. In this perspective, we examine the market forces driving growth, […]

The specialty care landscape is entering a new phase of transformation. Historically anchored in episodic, office-based interactions, specialty care is being reshaped by rising chronic disease prevalence, aging populations, advances in remote monitoring, and expanding reimbursement for virtual care. As more care shifts into the home, specialty providers have an opportunity to evolve from consultative […]

The HME/DME sector is at a strategic inflection point. Historically viewed as a margin-constrained distribution business, it is being reshaped by demographic growth, rising chronic disease burden, evolving reimbursement, and connected device proliferation. As care increasingly shifts into the home, HME/DME providers are uniquely positioned to evolve from equipment fulfillment to scalable, home-embedded clinical infrastructure. […]

Hospice remains essential to serious illness care, supported by strong beneficiary satisfaction and a growing national preference to age at home. Yet the landscape is shifting as regulators increase scrutiny, workforce shortages strain delivery, and payers link reimbursement to measurable outcomes, equity, and demonstrated value. This perspective explains how hospice is evolving from a standalone […]

Remote patient monitoring (RPM) has advanced far beyond its early pilot-era shortcomings. What once suffered from inconsistent oversight, unreliable data, and unclear clinical value has matured into a physician-led, accountable, and outcomes-focused element of modern chronic and virtual care. Today’s leading programs demonstrate sustained engagement, timely clinical action, and verifiable results, yet many payers and […]

As markets evolve and businesses expand, many organizations find their strategy has outpaced their story. The message that once fueled growth no longer captures their full value—creating confusion for customers, investors, and employees. In a fast-moving environment, lack of message clarity quietly erodes performance and alignment. This paper explores why message discipline is now a […]

Demand for CPAP therapy remains strong, but payers now expect measurable outcomes—early adherence, long-term persistence, and cardiometabolic impact—not just timely equipment delivery. This paper examines the market forces reshaping sleep care, from virtual intake and connected devices to payer-driven metrics and integrated care pathways. It highlights strategies for suppliers to expand beyond logistics, including remote […]

The shift from fee-for-service to value-based care is redefining what it takes for providers to succeed. Health systems, physician groups, and specialty practices must now excel clinically while proving their value to payers, patients, and regulators. This white paper examines the most common operational weaknesses holding providers back – from fragmented prior authorization processes to […]

The post-pandemic healthcare landscape presents unprecedented financial challenges. From persistent workforce shortages to rising costs and tightening reimbursement, hospitals and health systems are operating on razor-thin margins. This white paper offers a critical look at these pressures and provides actionable strategies for building a more resilient and profitable future. This paper outlines the essential pillars […]